EDTUTC-4 New YorkLog in Sign up

BMRN
BioMarin Pharmaceuticals Inc
stockNASDAQ

At CloseOct 29, 2026 3:59:59 PM EDT

57.42USD+2.536%(+1.42)2,616,555

Pre-marketOct 29, 2026 8:20:30 AM EDT

56.40USD+0.714%(+0.40)

After-hoursOct 29, 2026 4:31:30 PM EDT

57.72USD+0.519%(+0.30)

57.39Bid57.42Ask0.03Spread

BMRN News

Day breaks

09:05 AM EDTBioMarin Presents New Data Advancing Understanding of Achondroplasia and Hypochondroplasia Treatment at the American Society for Bone and Mineral Research Annual Meeting ·

PR Newswire

06:28 PM EDTBioMarin Q3 financial results to see IPR&D expense impact of $283M ·

Seeking Alpha

04:05 PM EDTBioMarin Appoints Cara Bauer as Chief People Officer ·

PR Newswire

02:33 PM EDTWhat's next for personalized mRNA cancer vaccines? ·

Seeking Alpha

11:00 AM EDTBioMarin Announces Five-Year Phase 3 Data for POMBILITI® (cipaglucosidase alfa-atga) + OPFOLDA® (miglustat) at World Muscle Society Annual Congress ·

PR Newswire

09:09 AM EDTBioMarin halts studies for Voxzogo in Noonan syndrome ·

Seeking Alpha

12:28 PM EDTHow BioMarin Turned a Competitive Threat Into a Royalty-Bearing Asset ·

Zacks Investment Research